Western Health Advantage
Braftovi (encorafenib)
Drugs for Cancer : Drugs for Cancer
  • Step Therapy: ST_APPLIES
  • Prior Authorization: PA Required
  • Prior Authorization: Pseudo-Bulbar Affect:
    Documented Diagnosis: Yes
    Duration: 3 Month(s)
    Reauthorization Required: Yes

  • Pain Narcotic: Opioid:
    Duration: 24 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 6 month(s)
    Diagnosis Type(s): 2 of Chronic Pain;Moderate to Severe Pain
    Used for Cancer Patients: Yes
    Around-The-Clock Analgesic Required: Yes
    Morphine Equivalent Dose (MED) Limit: N/A
    Morphine Equivalent Dose (MED) Required: No